Zhenzhong Ma

  • Vanderbilt University

    New ketamine study promises extended relief for depression

    Major depression is one of the most common mental disorders in the U.S. Approximately 7% (17.3 million) of American adults had at least one major depressive episode in 2017. Roughly 10 percent of the U.S. population is afflicted with major depressive disorder at any… Read More

    Jun. 13, 2025

  • A 3D rendering of several neural synapses.

    New ketamine study promises extended relief for depression

    For the nearly 30 percent of major depressive disorder patients who are resistant to treatment, ketamine provides some amount of normalcy, but it requires frequent treatment and can have side effects. Vanderbilt researchers now show in proof-of-concept experiments that it may be possible to extend ketamine’s antidepressant effect from about a week to up to two months. Read More

    May. 22, 2025

  • Headshots of the recent Basic Sciences promotions and appointment. Vanderbilt University gold background, Basic Sciences logo bottom right,

    Celebrating recent appointments and promotions in the School of Medicine Basic Sciences

    We extend congratulations to our many community members who were recently promoted or received new appointments. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read More

    Jan. 24, 2024